Group visits may help underserved kids with diabetes
NCT ID NCT05431686
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested whether shared medical appointments (group visits) could help underserved children aged 8–12 with poorly controlled type 1 diabetes. The 14 participants attended group visits every 3 months for a year, focusing on using diabetes technology and improving blood sugar control. The study measured how many families agreed to join, how often they attended, and their satisfaction with the program.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- shared medical appointments (behavioral intervention)
- What this could lead to
- If successful, this approach could offer a practical way to help high-risk children with type 1 diabetes better manage their condition and use glucose monitors.
- What could go wrong
- This is a very small pilot study with only 14 participants, so results may not apply to larger groups. It tests feasibility, not effectiveness, and may not lead to clear health improvements.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
14 people
The number who actually took part.
- Started
-
Feb 2022
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
8 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients clinically diagnosed with T1D managed with insulin injections for at least 1 year * Non-Hispanic Black or Latinx ethnicity * Public healthcare insurance * Male or female ages ≥ 8 and \< 12 years * Poorly controlled T1D: one A1c value \> 8% in the preceding year * Fluent in English as the Dexcom technology is currently available only in English * Participation of the primary diabetes caregiver Exclusion Criteria: * Use of insulin pump therapy for diabetes management at time of enrollment * Major illnesses other than T1D * Significant cognitive limitations and major psychiatric disorders in the child or * Concurrent use of any non-insulin diabetes medication to control blood glucose levels. * Concurrent participation in any other clinical studies during study period
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Type 1 diabetes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's National Hospital
Washington D.C., District of Columbia, 20010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tiny horses, big lessons: can ponies help kids tame diabetes?
- Can a math model tune insulin pumps better than standard care?
- Can a group program stop eating disorders in type 1 diabetes?
- Can a Two-Punch immune therapy save insulin cells in newly diagnosed diabetes?
- Can a smart insulin pump tailored for pregnancy protect mothers and babies?
- Can an automated pancreas system make type 1 diabetes safer in the real world?